Lili Li
Key Laboratory Of Anti Inflammatory And Immunopharmacology
Hefei, 230032, China
Hefei, 230032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Inhibition of MST1/2 attenuates the anti-hepatocarcinogenesis effect of Salvianolic acid B via the ERK/MAPK signaling pathway.
Journal: European journal of pharmacology
Published: December 31, 2025
Gasotransmitter-Nanodonor for Spatial Regulation of Anxiety-Like Behavior and Bone Metastasis.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: October 28, 2024
Salvianolic acid B ameliorates hepatic fibrosis via inhibiting p300/CBP.
Journal: European journal of pharmacology
Published: August 06, 2024
Nrf2 knockout attenuates the astragaloside IV therapeutic effect on kidney fibrosis from liver cancer by regulating pSmad3C/3L pathways.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: March 29, 2023
Astragaloside IV suppresses migration and invasion of TGF-β1-induced human hepatoma HuH-7 cells by regulating Nrf2/HO-1 and TGF-β1/Smad3 pathways.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: October 15, 2021
Astragaloside IV inhibits hepatocellular carcinoma by continually suppressing the development of fibrosis and regulating pSmad3C/3L and Nrf2/HO-1 pathways.
Journal: Journal of ethnopharmacology
Published: April 28, 2021
Smad3 gene C-terminal phosphorylation site mutation exacerbates CCl4-induced hepatic fibrogenesis by promoting pSmad2L/C-mediated signaling transduction.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: March 25, 2021
Smad3 C-terminal phosphorylation site mutation attenuates the hepatoprotective effect of salvianolic acid B against hepatocarcinogenesis.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: August 05, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026